{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:43:56Z","timestamp":1792424636509,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":5819,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1046\/j.1523-1755.2000.00837.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:32:45Z","timestamp":1047461565000},"page":"50-58","source":"Crossref","is-referenced-by-count":98,"title":["Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism"],"prefix":"10.1016","volume":"57","author":[{"given":"Michihito","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0010","series-title":"Renal Osteodystrophy","first-page":"129","article-title":"Parathyroid hormone in health and chronic renal disease,","author":"Slatopolsky","year":"1998"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0015","series-title":"The Parathyroids","first-page":"519","article-title":"Hyperparathyroidism in renal failure: Clinical features, diagnosis, and management,","author":"Coburn","year":"1994"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0020","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","article-title":"Renal osteodystrophy in adults and children,","author":"Goodman","year":"1996"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ki.1997.297","article-title":"The hyperparathyroidism of chronic renal failure: A disorder of growth","volume":"52","author":"Parfitt","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0030","series-title":"Renal Osteodystrophy","first-page":"283","article-title":"High-turnover renal osteodystrophy,","author":"Bushinsky","year":"1998"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S8756-3282(98)00098-2","article-title":"Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency","volume":"23","author":"Miller","year":"1998","journal-title":"Bone"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0040","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0045","first-page":"F432","article-title":"Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol","volume":"259","author":"Lopez-Hilker","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0050","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth: High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0055","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0060","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM198706183162504","article-title":"Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure","volume":"316","author":"Korkor","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.1989.3","article-title":"1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs","volume":"35","author":"Brown","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0070","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0075","first-page":"3130","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Decreased expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0085","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","article-title":"Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate","volume":"55","author":"Brown","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0090","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency: Control of parathyroid cell growth via a calcium receptor","volume":"100","author":"Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0095","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0100","first-page":"473","article-title":"NPS R-568: A type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium","volume":"290","author":"Fox","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/ENDO:10:2:97","article-title":"The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism","volume":"10","author":"Fox","year":"1999","journal-title":"Endocrine"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0110","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0115","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199711203372104","article-title":"Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism","volume":"337","author":"Silverberg","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1523-1755.1998.00735.x","article-title":"A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure","volume":"53","author":"Antonsen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0125","series-title":"Stereological Methods","author":"Weibel","year":"1979"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2818.1985.tb02607.x","article-title":"Stereological estimation of the-weighted mean, of arbitrary particles observed on random sections","volume":"138","author":"Gunderson","year":"1985","journal-title":"J Microsc"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0135","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1046\/j.1523-1755.1998.00221.x","article-title":"Effect of serum phosphate on parathyroid hormone secretion during hemodialysis","volume":"54","author":"De Francisco","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0140","first-page":"15","article-title":"Role of phosphate retention in the progression of renal failure","volume":"122","author":"Loghman-Adham","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel\u00ae, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1046\/j.1523-1755.2000.00837.x_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/11.supp3.121","article-title":"Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: Results of a preliminary study","volume":"11","author":"Kurokawa","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0160","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-nor-1-\u03b1-dihydroxyvitamin D2 (Paracalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on dialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","article-title":"Bone histology in incipient and advanced renal failure","volume":"9","author":"Malluche","year":"1976","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"Br Med J"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0175","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0272-6386(95)90570-7","article-title":"Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure","volume":"25","author":"Tsukamoto","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.me.43.020192.001303","article-title":"The use of 1,25-dihydroxyvitamin D3 in early renal failure","volume":"43","author":"Goodman","year":"1992","journal-title":"Annu Rev Med"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0190","first-page":"F611","article-title":"Localization of the extracellular Ca2+\/polyvalent cation-sensing receptor in rat kidney","volume":"274","author":"Riccardi","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0195","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/endo.140.5.6683","article-title":"Constitutive expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in a transformed human proximal tubule cell line: Evidence for direct regulation of vitamin D metabolism by calcium","volume":"140","author":"Bland","year":"1999","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0200","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0272-6386(96)90473-4","article-title":"Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure","volume":"28","author":"Denda","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0205","first-page":"175","article-title":"Regulation of parathyroid hormone synthesis and secretion","volume":"14","author":"Silver","year":"1994","journal-title":"Semin Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0210","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure: An evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00837.x_bb0215","unstructured":"Wada M, Furaya Y, Ishii H, Fox J, Nemeth EF, Nagano N: Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia. Bone (in press)"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815467055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815467055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T16:28:53Z","timestamp":1648830533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815467055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0085253815467055"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00837.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}